These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23692367)

  • 1. Athlete support personnel and anti-doping: Knowledge, attitudes, and ethical stance.
    Mazanov J; Backhouse S; Connor J; Hemphill D; Quirk F
    Scand J Med Sci Sports; 2014 Oct; 24(5):846-56. PubMed ID: 23692367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, attitudes and beliefs of technical staff towards doping in Spanish football.
    Morente-Sánchez J; Zabala M
    J Sports Sci; 2015; 33(12):1267-75. PubMed ID: 25574905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping in sports: knowledge and attitudes among parents of Austrian junior athletes.
    Blank C; Leichtfried V; Schaiter R; Fürhapter C; Müller D; Schobersberger W
    Scand J Med Sci Sports; 2015 Feb; 25(1):116-24. PubMed ID: 24372621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General practitioners and doping in sports: knowledge and attitudes].
    Laure P
    Sante Publique; 1997 Jun; 9(2):145-56. PubMed ID: 9417372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doping knowledge, attitudes, and practices of Ugandan athletes': a cross-sectional study.
    Muwonge H; Zavuga R; Kabenge PA
    Subst Abuse Treat Prev Policy; 2015 Sep; 10():37. PubMed ID: 26395767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs.
    Backhouse SH; McKenna J
    Int J Drug Policy; 2011 May; 22(3):198-202. PubMed ID: 21481579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary supplement and drug use and doping knowledge and attitudes in Italian young elite cyclists.
    Loraschi A; Galli N; Cosentino M
    Clin J Sport Med; 2014 May; 24(3):238-44. PubMed ID: 24184855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Korean national athletes' knowledge, practices, and attitudes of doping: a cross-sectional study.
    Kim T; Kim YH
    Subst Abuse Treat Prev Policy; 2017 Feb; 12(1):7. PubMed ID: 28196542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug misuse in sport: a New Zealand perspective.
    Curtis A; Gerrard D; Burt P; Osborne H
    N Z Med J; 2015 Dec; 128(1426):62-8. PubMed ID: 26913908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the athletes' entourage on attitudes to doping.
    Barkoukis V; Brooke L; Ntoumanis N; Smith B; Gucciardi DF
    J Sports Sci; 2019 Nov; 37(21):2483-2491. PubMed ID: 31362583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative evidence of a primary intervention point for elite athlete doping.
    Mazanov J; Huybers T; Connor J
    J Sci Med Sport; 2011 Mar; 14(2):106-10. PubMed ID: 20708965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sports physicians, ethics and antidoping governance: between assistance and negligence.
    Dikic N; McNamee M; Günter H; Markovic SS; Vajgic B
    Br J Sports Med; 2013 Jul; 47(11):701-4. PubMed ID: 23322892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and doping in elite-level cycling.
    Lentillon-Kaestner V; Hagger MS; Hardcastle S
    Scand J Med Sci Sports; 2012 Oct; 22(5):596-606. PubMed ID: 21392123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners knowledge, practice and training requirements in relation to doping in sport.
    Woods CB; Moynihan A
    Ir Med J; 2009 Jan; 102(1):8-10. PubMed ID: 19284009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.